[Features of liver damage caused by 17-alpha-alkyl-substituted anabolic steroids].
D045930:Anabolic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000818:Animals; D056486:Chemical and Drug Induced Liver Injury; D002779:Cholestasis / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003280:Contraceptives, Oral, Synthetic / Q000009:adverse effects*; D045166:Estradiol Congeners / Q000009:adverse effects; D006801:Humans; D008099:Liver / Q000098:blood supply / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D008107:Liver Diseases / Q000473:pathology / Q000503:physiopathology; D008111:Liver Function Tests; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D045167:Progesterone Congeners / Q000009:adverse effects; D013329:Structure-Activity Relationship
D045930:Anabolic Agents; D003276:Contraceptives, Oral; D003280:Contraceptives, Oral, Synthetic; D045166:Estradiol Congeners; D045167:Progesterone Congeners
Aspetti del danno epatico da steroidi anabolizzanti: 17-alfa-alchil-sostituiti.